NCT00403169View on ClinicalTrials.gov

Lenalidomide in Treating Patients With Advanced or Unresectable Kidney Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

August 31, 2004

Primary Completion Date

May 31, 2009

Study Completion Date

May 31, 2009

Conditions
Kidney Cancer
Interventions
DRUG

lenalidomide

drug

Trial Locations (1)

44106-5065

Case Comprehensive Cancer Center, Cleveland

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

The Cleveland Clinic

OTHER

NCT00403169 - Lenalidomide in Treating Patients With Advanced or Unresectable Kidney Cancer | Biotech Hunter | Biotech Hunter